RecruitingNCT05522374
TIRCON International NBIA Registry
Studying Aceruloplasminemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- LMU Klinikum
- Principal Investigator
- Thomas Klopstock, Prof. Dr.LMU Klinikum, Friedrich-Baur-Institute
- Enrollment
- 2000 enrolled
- Eligibility
- All sexes
- Timeline
- 2012 – 2040
Study locations (9)
- Children's Hospital of Eastern Ontario, Division of Neurology, Department of Pediatrics, Ottawa, Canada
- Charles University, Department of neurology, Prague, Czechia
- LMU Klinikum, Friedrich-Baur-Institute, Munich, Bavaria, Germany
- The Foundation of the Carlo Besta Neurological Institute, IRCCS, Milan, Italy
- University medical Center Groningen (UMCG) Department of Neurology AB 51, Groningen, Netherlands
- The Childrens Memorial Health Institute, Warsaw, Poland
- University of Belgrade, Department of Movement Disorders and Degenerative Brain Diseases, Belgrade, Serbia
- Hospital Vall d'Hebron - Institut de Recerca (VHIR), Pediatric Neurology, Movement Disorders, Barcelona, Spain
- Hospital Sant Joan de Déu, Universitat de Barcelona, Servei de Neurología, Barcelona, Spain
Collaborators
Seventh Framework Programme · NBIA Alliance
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05522374 on ClinicalTrials.gov